Skip to main content

August 2025

Crack GPAT — Prepare for GPAT Online 

University of Hyderabad Hiring PG in Biochemistry, Biotechnology, Bioinformatics candidates

MSc / MTech. in Biochemistry / Biotechnology / Bioinformatics, Science and Engineering Research Board SERB research at University of Hyderabad
Life Sciences, Biotechnology, Biochemistry Openings at NIPGR
Masters Degree in Molecular Biology / Biochemistry / Plant Science / Life Sciences / Biotechnology or Bachelor degree in Engineering or Technology or Medicine at NIPGR, Delhi
NIBMG Hiring Life Sciences, Biotechnology, Microbiology candidates
MSc in Biotechnology / Zoology / Molecular biology / Microbiology or related field in Life Sciences. National Institute of Biomedical Genomics
IGIB Openings for Biotechnology, Microbiology, Bioinformatics
Masters in Biotechnology, Bioinformatics, Computational biology, Data Science. Proven experience in front-end and/or back-end development of web portals or similar applications. Institute of Genomics & Integrative Biology
Hiring B.Pharm, BSc in Multiple Department at Torrent Pharma
Knowledge of Documentation, QMS, Deviation, Change Control, market Complaint, 00S, 00T, Validation Qualification, IPQA, Audit Compliance.
Walk in Drive for M.Pharm, B.Pharm, MSc in Production, QC, QA at Apotex Inc
Handle, supervise the manufacturing process and related activities of Compounding, Dosing section & Packing
Vanda won Federal appeal to overturn FDA Denying Approval of Hetlioz
Vanda Pharmaceuticals Inc. (Vanda) announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its longstanding dispute with the agency regarding the approvability of HETLIOZ® (tasimelteon) to treat jet lag disorder
Alembic Pharmaceuticals Limited announces USFDA Final approval for Macitentan Tablets, 10 mg
Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Macitentan Tablets, 10 mg.
Novo Nordisk Wegovy approved in the US for the treatment of MASH
The U.S. Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis (excessive scar tissue in the liver).
Interview for M.Pharm, MSc to select around 27 posts at IICB
Masters of Science in Chemistry. 3 years experience in Research and Development in Industrial and Academic Institutions or Science and Technology Organizations and Scientific activities and services